|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/48 | |
| C07F 9/6512 | |||
| A61P 31/20 |
| (11) | Number of the document | 2155257 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08743275.3 |
| Date of filing the European patent application | 2008-04-25 | |
| (97) | Date of publication of the European application | 2010-02-24 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/005322 |
| Date | 2008-04-25 |
| (87) | Number | WO 2008/133966 |
| Date | 2008-11-06 |
| (30) | Number | Date | Country code |
| 914532 P | 2007-04-27 | US |
| (72) |
PAINTER, George R., US
|
| (73) |
Chimerix, Inc.,
2505 Meridian Parkway, Suite 340, Durham, NC 27713,
US
|
| (54) | METHODS OF REDUCING NEPHROTOXICITY IN SUBJECTS ADMINISTERED WITH NUCLEOSIDE |
| METHODS OF REDUCING NEPHROTOXICITY IN SUBJECTS ADMINISTERED WITH NUCLEOSIDE |